“biotech” Archives

in
Entry Author Date Location
Amplyx Inks Novartis Deal for Another Compromised-Immune System Drug 09/17/19 San Diego
Lundbeck Paying Nearly $2B for Alder to Follow Migraine Rivals to Market 09/16/19 National
Advisory Body Backs Aimmune Peanut Allergy Drug, Next Up: the FDA 09/13/19 San Francisco
BACEless: Eisai, Biogen Pull Plug on Alzheimer’s Drug in Final Stage 09/13/19 New York
SpringWorks and Satsuma Boost This Week’s Biotech IPO Haul to $595M 09/12/19 San Francisco
The Winners of the 2019 Xconomy Awards Boston Are… 09/12/19 Boston
Tocagen Stock Tanks After Gene Therapy Drug for Brain Cancer Fails 09/12/19 San Diego
FDA Doesn’t Shell Peanut Allergy Drug Pre-Hearing, Aimmune Shares Climb 09/11/19 San Francisco
After Investing, GSK to Buy Out Celiac Drug Developer Sitari Pharma 09/11/19 San Diego
After First Look at House Drug Plan, Stocks Rise Slightly 09/10/19 National
BlackThorn Therapeutics Names Monique Levy Chief Strategy Officer 09/10/19 San Francisco
Challenging CRISPR, Trucode Raises $34M for New Gene-Editing System 09/10/19 San Francisco
San Diego Life Sciences Roundup: SGI-DNA, ZeaKal, DelMar Pharma & More 09/10/19 San Diego
Acadia Stock Jumps on Positive Dementia-Related Psychosis Drug Data 09/09/19 San Diego
Genfit Names Carol Addy to Chief Medical Officer Role 09/09/19 Boston
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds 09/06/19 Boston
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone 09/06/19 National
Novartis & IFM Team Up Again, With Buyout Option for Autoimmune R&D 09/05/19 Boston
Startup Aquacycl Raises $4M To More Efficiently Treat Wastewater 09/05/19 San Diego
Synlogic’s C-Suite Adds Richard Riese, CFO Todd Shegog to Depart 09/04/19 Boston
Bankrupt uBiome Says Founders May Have Misled Investors 09/04/19 San Francisco
Bolt Biotherapeutics Taps Ex-Alder Executive Randy Schatzman as CEO 09/04/19 San Francisco
Former Nightstar Exec Gregory Robinson Joins Akouos as Chief Scientific Officer 09/04/19 Boston
Vir Bio Plans IPO to Fund Clinical Trials of Infectious Disease Drugs 09/03/19 San Francisco
Accent Therapeutics Taps Tango’s Shakti Narayan for CEO 09/03/19 Boston
Former Alnylam Executive Soni Joins Reata Pharmaceuticals as CFO 09/03/19 Texas
Aristea Therapeutics Taps Nihar Bhakta as Chief Medical Officer 09/03/19 San Diego
Vertex Bets $950M on Semma and a Stem Cell Therapy for Diabetes 09/03/19 Boston
Patent Challenge to Alexion Proceeds, But No Amgen Biosimilar Yet 08/30/19 Boston
Bio Roundup: Cholesterol Check, J&J’s Opioid Hit, AbbVie’s Flop & More 08/30/19 National
Page 1 of 305 next page »